Table 2.

Meta-analysis of nivolumab in terms of rate of common AEs

Types of common AEs	Any grade rate (%)	95% CI	Grade 3/4 rate (%)	95% CI
Fatigue	0.28	0.09–0.33	0.08	0.06–0.11
Nausea	0.12	0.09–0.16	0.03	0–0.23
Asthenia	0.1	0.08–0.13	0.02	0–0.36
Anemia	0.03	0.01–0.03	0.01	0–0.01
Decreased appetite	0.13	0.09–0.17	0.01	0–0.02
Myalgia	0.03	0.02–0.05	0.01	0–0.02
Pneumonitis	0.04	0.02–0.06	0.01	0–0.03
Rash	0.04	0.02–0.06	0.01	0–0.02
Diarrhea	0.08	0.06–0.11	0.01	0–0.02

Abbreviations: AEs, adverse effects; CI, confidence interval.